These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. BET bromodomain proteins regulate enhancer function during adipogenesis. Brown JD; Feldman ZB; Doherty SP; Reyes JM; Rahl PB; Lin CY; Sheng Q; Duan Q; Federation AJ; Kung AL; Haldar SM; Young RA; Plutzky J; Bradner JE Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2144-2149. PubMed ID: 29444854 [TBL] [Abstract][Full Text] [Related]
27. Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2. Umehara T; Nakamura Y; Wakamori M; Ozato K; Yokoyama S; Padmanabhan B FEBS Lett; 2010 Sep; 584(18):3901-8. PubMed ID: 20709061 [TBL] [Abstract][Full Text] [Related]
28. Regulation and function of AMPK in physiology and diseases. Jeon SM Exp Mol Med; 2016 Jul; 48(7):e245. PubMed ID: 27416781 [TBL] [Abstract][Full Text] [Related]
29. A noncanonical bromodomain in the AAA ATPase protein Yta7 directs chromosomal positioning and barrier chromatin activity. Gradolatto A; Smart SK; Byrum S; Blair LP; Rogers RS; Kolar EA; Lavender H; Larson SK; Aitchison JD; Taverna SD; Tackett AJ Mol Cell Biol; 2009 Sep; 29(17):4604-11. PubMed ID: 19581291 [TBL] [Abstract][Full Text] [Related]
30. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598 [TBL] [Abstract][Full Text] [Related]
31. New insights into TNFα/PTP1B and PPARγ pathway through RNF213- a link between inflammation, obesity, insulin resistance, and Moyamoya disease. Sarkar P; Thirumurugan K Gene; 2021 Mar; 771():145340. PubMed ID: 33333224 [TBL] [Abstract][Full Text] [Related]
32. MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes. Coope A; Torsoni AS; Velloso LA Eur J Endocrinol; 2016 May; 174(5):R175-87. PubMed ID: 26646937 [TBL] [Abstract][Full Text] [Related]
34. A mechanism for epigenetic control of DNA replication. Sansam CG; Pietrzak K; Majchrzycka B; Kerlin MA; Chen J; Rankin S; Sansam CL Genes Dev; 2018 Feb; 32(3-4):224-229. PubMed ID: 29483155 [TBL] [Abstract][Full Text] [Related]
35. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors. Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217 [TBL] [Abstract][Full Text] [Related]
36. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. Khodabandehloo H; Gorgani-Firuzjaee S; Panahi G; Meshkani R Transl Res; 2016 Jan; 167(1):228-56. PubMed ID: 26408801 [TBL] [Abstract][Full Text] [Related]
37. Bromodomain inhibitors and cancer therapy: From structures to applications. Pérez-Salvia M; Esteller M Epigenetics; 2017 May; 12(5):323-339. PubMed ID: 27911230 [TBL] [Abstract][Full Text] [Related]